Učitavanje...
Thiazolidinediones and Cardiovascular Risk — A Question of Balance
BACKGROUND: Several recent meta-analyses of adverse event data from randomized controlled trials with rosiglitazone reveal a possible association between this thiazolidinedione and an increased risk of ischemic myocardial events. This has led to debate on the overall clinical benefit of glitazone th...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bentham Science Publishers Ltd.
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2822138/ https://ncbi.nlm.nih.gov/pubmed/20676274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/157340309788970333 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|